BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31567000)

  • 1. Features of Retinitis-like Lesions in Vitreoretinal Lymphoma.
    Marchese A; Agarwal A; Miserocchi E; Giuffrè C; Bandello F; Modorati G; Prakash G; Gupta N; Bosello F; Sharma SP; Gupta V
    Ocul Immunol Inflamm; 2021 Apr; 29(3):440-447. PubMed ID: 31567000
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodal Imaging of Vitreoretinal Lymphoma.
    Mapelli C; Invernizzi A; Barteselli G; Pellegrini M; Tabacchi E; Staurenghi G; Viola F
    Ophthalmologica; 2016; 236(3):166-174. PubMed ID: 27627063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
    Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
    Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
    Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
    Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
    Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
    Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
    Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
    Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
    Maggio E; Bauci F; Polito A; Arena F; Pertile G
    BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
    Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M;
    Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
    Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
    Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
    Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
    Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHORIORETINAL ATROPHY IN VITREORETINAL LYMPHOMA: Risk Factors and Visual Outcomes.
    Marchese A; Cicinelli MV; Cavalleri M; Bandello F; Modorati G; Miserocchi E
    Retina; 2022 Mar; 42(3):561-568. PubMed ID: 35188494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
    Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
    Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series.
    Cimino L; Coassin M; Chan CC; Marchi S; Belpoliti M; Fanti A; Iovieno A; Fontana L
    Indian J Ophthalmol; 2016 May; 64(5):369-75. PubMed ID: 27380976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
    Kase S; Namba K; Kanno-Okada H; Onozawa M; Hidaka D; Iwata D; Mizuuchi K; Fukuhara T; Fukuhara J; Kitaichi N; Matsuno Y; Ishida S
    Ocul Immunol Inflamm; 2020; 28(1):147-155. PubMed ID: 30335535
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T; Taoka K
    Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography manifestations of primary vitreoretinal lymphoma.
    Saito T; Ohguro N; Iwahashi C; Hashida N
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2319-2326. PubMed ID: 27251192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.